, Tracking Stock Market Picks
Enter Symbol:
Echo Therapeutics (ECTE) [hlAlert]


Echo Therapeutics (ECTE) rated Outperform with price target $3 by Boenning & Scattergood

Posted on: Tuesday,  Dec 15, 2009  9:25 AM ET by Boenning & Scattergood

Echo Therapeutics (ECTE) rated
Outperform with price target $3 by Boenning & Scattergood.

Echo Therapeutics, Inc. (Echo) is a medical device and specialty pharmaceutical company. The Company is developing a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in clinical settings and for people with diabetes together with a range of transdermal reformulations of specialty pharmaceutical products approved by the United States Food and Drug Administration (FDA). The Symphony tCGM System is a non-invasive (needle-free), wireless tCGM system designed to provide blood glucose data. Symphony incorporates the feedback mechanism for optimal skin permeation control and the transdermal sensor to detect glucose trends, for controlling complications associated with blood glucose levels that stray outside of a target range. Symphony incorporates the skin permeation, transdermal sensor, wireless transmission and data display technologies. The specialty pharmaceuticals pipeline is based on the AzoneTS transdermal drug reformulation technology.

Our equity research team concentrates on companies that aren’t widely covered in sectors such as water distribution/equipment/technology, financial services, business services, aerospace & defense technology, medical technology and retail.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2009 9:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy